Corrigendum to “Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease” [Neurobiology of Disease, 2024 Jan:190:106376]

ElsevierVolume 193, April 2024, 106444Neurobiology of DiseaseAuthor links open overlay panelStefan Bartl a 1, Yuanyun Xie b c, Nalini Potluri b, Ratnesh Kesineni b, Katlin Hencak b, Louisa Dal Cengio c, Katja Balazs d, Abid Oueslati e, Michela Parth d, Nina Salhat d, Alberto Siddu e, Oskar Smrzka d 2, Francesca Cicchetti e, Günther Staffler d 3, Michael R. Hayden c, Amber L. Southwell bShow morePrevious article in issueNext article in issue

Recommended articles

1

Former address: AFFiRiS AG, Vienna, Austria.

2

Present address: Ablevia Biotech, Vienna, Austria.

3

Present address: AC Immune, Lausanne, Switzerland.

© 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Recommended articlesArticle Metrics

留言 (0)

沒有登入
gif